help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2009.090319 on August 21, 2009

Published online before print August 21, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2009.090319v1
175/3/1167    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Katsifis, G. E.
Right arrow Articles by Wahl, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katsifis, G. E.
Right arrow Articles by Wahl, S. M.
(American Journal of Pathology. 2009;175:1167-1177.)
Published 2009 by the American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.090319

Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis

Gikas E. Katsifis, Sofia Rekka, Niki M. Moutsopoulos, Stanley Pillemer and Sharon M. Wahl

From the Oral Infection and Immunity Branch, and Sjögren’s Syndrome Clinic, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland

Recently recognized as a distinct CD4+ T helper (Th) lineage, Th17 cells have been implicated in host responses to infections and in pathogenesis associated with autoimmune diseases. This cytokine is implicated in primary Sjögren’s syndrome (pSS) immunopathology because of the increased levels of circulating interleukin (IL)-17 in pSS. Plasma and minor salivary glands (MSGs) from patients with pSS were therefore evaluated for CD4+ T cells, T regulatory cells, IL-17, and supporting cytokines by immunohistochemistry, RT-PCR, and microbead assays. MSGs from pSS patients contain IL-17-expressing cells as a dominant population within inflammatory lesions. IL-17 protein expression progressively increased with higher biopsy focus scores (P < 0.0001), in parallel with detection by RT-PCR. Transforming growth factor-β, IL-6 and IL-23, which are requisite promoters of Th17 differentiation, were found in abundance compared with the amounts in control tissues. Although transforming growth factor-β is also a pivotal differentiation factor for immunosuppressive Foxp3+ T regulatory cells (Tregs), an increase in Foxp3+ Tregs was evident in biopsy specimens with mild and moderate inflammation but this increase was disproportionate to escalating pro-inflammatory Th17 populations in advanced disease. Furthermore, the Th17-centric cytokines IL-17, IL-6, IL-23, and IL-12 were significantly elevated in pSS plasma. These data identify a profusion of IL-17-generating cells and supporting cytokines within diseased pSS MSGs without a compensatory increase in immunomodulatory Tregs; this imbalance seems to foster a pathogenic milieu that may be causative and predictive of infiltrative injury and amenable to therapeutic intervention.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
C. S. De Paiva, C. S. Hwang, J. D. Pitcher III, S. B. Pangelinan, E. Rahimy, W. Chen, K.-C. Yoon, W. J. Farley, J. Y. Niederkorn, M. E. Stern, et al.
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice
Rheumatology, February 1, 2010; 49(2): 246 - 258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.